Combination of triazine derivatives and insulin sensitisers

Details for Australian Patent Application No. 2006334734 (hide)

Owner POXEL SAS

Inventors Cravo, Daniel; Moinet, Gerard; Mesangeau, Didier

Agent Davies Collison Cave

Pub. Number AU-B-2006334734

PCT Pub. Number WO2007/079917

Priority 06/00344 13.01.06 FR

Filing date 18 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 19 July 2012

International Classifications

A61K 31/166 - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/422 - not condensed and containing further heterocyclic rings

A61K 31/4439

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/079917 Priority application(s): WO2007/079917

16 July 2009 Assignment before Grant

  Merck Patent GmbH The application has been assigned to POXEL SAS

19 July 2012 Application Accepted

  Published as AU-B-2006334734

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006334735-Combination of triazine derivatives and PPAR&agr;agonists

2006334733-Combination of triazine derivatives and HMG-COA reductase inhibitors for the treatment of diabetes